The TIME-2 Study: A Phase 2 Study of AKB-9778, a Novel Tie-2 Activator, in Patients With Diabetic Macular Edema

Clinical trial NCT02050828 · COMPLETED

Trial details

NCT number: NCT02050828
Sponsor: Aerpio Therapeutics
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Diabetic Macular Edema (DME)

Start date: 2014-01-01
Primary completion: 2015-04-01
Enrollment: 144

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.